Topical Cellulitis Composition for Shorter Treatment and Surgical Prophylaxis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cellulitis, particularly post-surgical cellulitis, often require prolonged use of oral or intravenous antibiotics, which can lead to side effects and complications, and there is a need for more effective and less invasive methods to manage and prevent this condition.
Innovation Solution
A topical composition comprising 85% transdermal cream, 5% Cephalexin, 5% Ketoprofen, and 5% Lidocaine is applied to the affected skin, with a density of 1 gram per milliliter, to treat cellulitis, and can be used up to 12 hours before surgical procedures to reduce the risk of infection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If oral or intravenous antibiotics are used to treat cellulitis, then the treatment effectiveness is improved, but the treatment duration is prolonged and side effects increase
Solution Approach 1:
The patent divides the treatment approach by separating the antibiotic delivery system into a topical cream formulation that can be applied directly to the affected skin area, rather than systemic administration. This segmentation allows localized treatment with reduced systemic exposure and shorter treatment duration while maintaining effectiveness.
Solution Approach 2:
The patent changes the administration parameter from systemic (oral/IV) to topical application, and modifies the antibiotic concentration in the cream formulation (e.g., 12.5mg/g of Cephalexin). This parameter change enables effective local treatment with reduced overall dosage and shorter treatment course.
2Reliability
If oral or intravenous antibiotics are used to treat cellulitis, then the treatment effectiveness is improved, but the side effects and complications increase
Solution Approach 1:
By segmenting the treatment to topical application only, the patent minimizes systemic absorption of antibiotics, thereby reducing side effects and complications associated with oral or IV antibiotic therapy while maintaining local treatment effectiveness.
Solution Approach 2:
The patent applies antibiotic cream locally to the affected cellulitis area, providing high concentration where needed while minimizing systemic exposure. This local quality approach treats the infection effectively without exposing the whole body to antibiotic side effects.
3Reliability
If topical composition is applied before surgical procedure, then the risk of infection is reduced, but the application complexity increases
Solution Approach 1:
The topical cream formulation serves multiple functions: it acts as an antibiotic prophylaxis before surgery, provides analgesic relief, and can be used for post-operative care as well. This multi-functionality simplifies the overall treatment protocol despite the pre-surgical application requirement.
Solution Approach 2:
The patent applies the antibiotic cream to the surgical site before the procedure (pre-surgical prophylaxis), preparing the skin in advance to reduce infection risk. This preliminary action is simple topical application that prevents infection without adding complex procedural steps.
Data Source
AI summary
A composition for treatment of cellulitus is provided that includes by weight: about 85% transdermal cream; an effective amount of at least one antibiotic; about 5% Ketoprofen; and about 5% Lidocaine. The composition has a density of about 1 gram per milliliter.